Volume 19, Number 8—August 2013
No Evidence for Hepatitis E Virus Genotype 3 Susceptibility in Rats
Highlight and copy the desired format.
|EID||Li T, Ami Y, Suzaki Y, Takeda N, Takaji W. No Evidence for Hepatitis E Virus Genotype 3 Susceptibility in Rats. Emerg Infect Dis. 2013;19(8):1343-1345. https://dx.doi.org/10.3201/eid1908.130200|
|AMA||Li T, Ami Y, Suzaki Y, et al. No Evidence for Hepatitis E Virus Genotype 3 Susceptibility in Rats. Emerging Infectious Diseases. 2013;19(8):1343-1345. doi:10.3201/eid1908.130200.|
|APA||Li, T., Ami, Y., Suzaki, Y., Takeda, N., & Takaji, W. (2013). No Evidence for Hepatitis E Virus Genotype 3 Susceptibility in Rats. Emerging Infectious Diseases, 19(8), 1343-1345. https://dx.doi.org/10.3201/eid1908.130200.|
To the editor: Hepatitis E virus (HEV) is a positive-sense single-stranded RNA virus (genus Hepevirus, family Hepeviridae) (1). In humans, acute hepatitis infection caused by HEV is a serious public health concern in developing countries. Four HEV genotypes, G1–4, have been isolated from humans (2). G3 and G4 HEV have also been isolated from swine, wild boars, wild deer, and mongooses; these animals are thought to be the reservoirs of HEV (3). Direct evidence has indicated that HEV is transmitted from pigs or wild boars to humans; therefore, hepatitis E caused by G3 and G4 HEV infection is recognized as a zoonosis (3).
Although rats have long been suspected to be a potential reservoir for human HEV, no direct evidence has been found. The susceptibility of rats to human HEV genotypes is controversial. For example, anti-HEV IgG has been detected in various rat species, including Norway (Rattus norvegicus), black (Rattus rattus), and cotton (Sigmodon hispidus) rats, by using ELISA with antigens derived from G1 HEV. These results suggest that HEV or HEV-like virus infections occur in wild rats. However, the virus genome has not been detected, and the source of the infection was confirmed in few cases; thus far, it is not clear whether the anti-HEV IgG was induced by HEV or other HEV-like viruses. The detection of a partial genome of G1 HEV from wild rats in Nepal was reported in 2002 (4); however, this report was retracted in 2006 because the isolated strain was determined to be a result of laboratory contamination. Recently, Lack et al. isolated strains of G3 HEV from a variety species of wild rats in the United States (5); this finding suggests that wild rats are hosts for G3 HEV. Maneerat et al. also reported that human HEV (presumably G1) was transmissible to Wistar laboratory rats (6). However, Purcell et al. recently reported that G1, G2, and G3 do not infect laboratory rats (7), and we found in a previous study that laboratory rats are not susceptible to G1, G3, or G4 HEV (8).
To further investigate the potential susceptibility of rats to infection with human HEV, we experimentally injected nude rats with G3 HEV and monitored virus growth. We used 2 samples of G3 HEV for the infection experiments, 1 derived from fecal specimens collected from a pig farm in Japan (GenBank accession no. DQ079632) and 1 derived from the supernatant of a hepatocarcinoma cell line, PLC/PRF/5, that was injected with the pig specimen. The infectivity of these samples was confirmed by experimental infections of cynomolgus monkeys (9; data not shown).
Six 15-week-old female nude rats (athymic rats, Long-Evans-run/run; Japan SLC, Inc., Hamamatsu, Japan) were used in this study. These rats, which are bred to be immunodeficient, are known to be susceptible to rat HEV, but it is unknown if they are susceptible to other types of HEV. All rats were negative for G3 HEV RNA and anti-HEV antibodies, as determined by nested reverse transcription PCR (10) and ELISA (8), respectively. Rats were housed individually in biosafety level 2 facilities. Experiments were reviewed by the ethics committee of the National Institute of Infectious Diseases (NIID) Japan and carried out according to the “Guidelines for animal experiments performed at NIID” under code 113060.
The 6 rats were randomly assigned to 2 groups, injected intravenously with 500 µL of an HEV sample suspension through the tail vein, and monitored for 3 months. The 3 rats in group 1 were injected with the sample derived from pig feces, which contained 5 × 104 copies of G3 HEV; the 3 rats in group 2 were injected with the cell culture supernatant sample, which contained 4 × 106 copies of G3 HEV. Serum samples were collected weekly for examination of HEV RNA and anti-HEV IgG and IgM and were also used to determine alanine aminotransferase values. Fecal samples were collected every 3 days to detect HEV RNA. The animals were humanly killed by exsanguination 91 days postinjection, liver tissues were collected, and a 10% tissue suspension was prepared as described (8).
For groups 1 and 2, all serum samples collected 1–13 weeks postinjection were negative for HEV RNA and anti-HEV IgG and IgM. HEV RNA also was not detected in fecal samples or liver tissues. Alanine aminotransferase elevation was not observed in any serum samples.
In conclusion, even by using samples with high titers of HEV RNA in injection experiments, we were unable to cause infection with G3 HEV in immunodeficient nude rats. We found no evidence that rats are susceptible to infection with G3 HEV.
This study was supported in part by grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labour and Welfare, Japan.
- Meng XJ, Anderson DA, Arankalle VA, Emerson SU, Harrison TJ, Jameel S, Hepeviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus taxonomy: ninth report of the ICTV. London: Elsevier/Academic Press; 2012. p. 1021–28.
- Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol. 2003;13:145–54 and.
- Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol. 2010;140:256–65 and.
- He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. [Retracted in: He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, et al. J Clin Microbiol. 2006;44:1208. ]. J Clin Microbiol. 2002;40:4493–8.
- Lack JB, Volk K, Van Den Bussche RA. Hepatitis E virus genotype 3 in wild rats, United States. Emerg Infect Dis. 2012;18:1268–73 and.
- Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL. Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol. 1996;48:121–8 and.
- Purcell RH, Engle RE, Rood MP, Kabrane-Lazizi Y, Nguyen HT, Govindarajan S, Hepatitis E virus in rats, Los Angeles, California, USA. Emerg Infect Dis. 2011;17:2216–22 and.
- Li TC, Yoshizaki S, Ami Y, Suzaki Y, Yasuda SP, Yoshimatsu K, Susceptibility of laboratory rats against genotypes 1, 3, 4, and rat hepatitis E viruses. Vet Microbiol. 2013;163:54–61 and.
- Li TC, Suzaki Y, Ami Y, Tsunemitsu H, Miyamura T, Takeda N. Mice are not susceptible to hepatitis E virus infection. J Vet Med Sci. 2008;70:1359–62 and.
- Johne R, Plenge-Bonig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol. 2010;91:750–8 and.
TableCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Tian-Cheng Li, Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-murayama, Tokyo 208-0011, Japan
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 03, 2013
- Page last updated: July 03, 2013
- Page last reviewed: July 03, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)